Gazyvaro 1,000 mg concentrate for solution for infusion.
APHP230848
Phase 2 small_molecule active
Quick answer
Gazyvaro 1,000 mg concentrate for solution for infusion. for Non-infectious active cryoglobulinemia vasculitis who are either refractory or intolerant to Rituximab is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Non-infectious active cryoglobulinemia vasculitis who are either refractory or intolerant to Rituximab
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active